amosulalol has been researched along with Diabetes Mellitus, Type 2 in 1 studies
amosulalol: RN given is for mono-HCl; structure given in first source
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, Y | 1 |
| Yaga, K | 1 |
| Nishimura, M | 1 |
| Okafuji, K | 1 |
| Fujii, Y | 1 |
| Nagasaka, Y | 1 |
| Tanaka, M | 1 |
| Fujita, N | 1 |
| Kaku, K | 1 |
| Kaneko, T | 1 |
1 other study available for amosulalol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Antihypertensive and metabolic effects of long-term treatment with amosulalol in non-insulin dependent diabetics.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Cholesterol, HDL; Diabetes Mellitus, Type 2; Di | 1992 |